Real-World Utilization Patterns, Safety, and Efficacy of Tafamidis in Patients With Hereditary Transthyretin Amyloidosis in Japan
Authors
- Noriko Matsumoto (ORCID: https://orcid.org/0000-0002-4054-9597)
- Yoshiki Sekijima (ORCID: https://orcid.org/0000-0002-8132-2743)
- Yukio Ando (ORCID: https://orcid.org/0000-0001-7115-9105)
- Mitsuharu Ueda (ORCID: https://orcid.org/0000-0002-6814-0582)
- Hajime Abe (ORCID: https://orcid.org/0000-0003-1078-5318)
- Yutaka Endo (ORCID: https://orcid.org/0000-0003-2006-7707)
- Hiroaki Konishi
Institutions
- Shinshu University (JP)
- Amyloidosis Foundation (US)
- Pfizer (Japan) (JP)
- Kumamoto University (JP)